Q1: 2026-05-06 Earnings Summary EPS of -$0.85 misses by $1.33  |  Revenue of -$29.00K (-100.96% Y/Y) misses by $109.31M Vir Biotechnology, Inc. ( VIR ) Bank of America Global Healthcare Conference 2026 May 12, 2026 7:20 PM EDT Company Participants Marianne De Backer - President, CEO & Director Conference Call Participants Alec Stranahan - BofA Securities, Research Division Presentation Alec Stranahan BofA Securities, Research Division Thanks for joining the session with Vir Biotechnology. My name is Alec Stranahan. I cover SMID-cap biotech at Bank of America, and I'm the covering analyst for Vir. And it's my pleasure to introduce Marianne De Backer, Chief Executive Officer of Vir. Marianne, thanks for being here. Marianne De Backer President, CEO & Director Yes, my pleasure. Thank you. Question-and-Answer Session Alec Stranahan BofA Securities, Research Division Looking forward to the discussion. I guess just jumping right into it, you've effectively built a 2-engine value story for Vir.…